CBUS
Cibus, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.59
−2.45%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$1.60
From 52W high−60.74%
Volume73100.00
Market cap$121.52M
P/E (TTM)—
P/S (TTM)28.0x
Div yield—
Key dataSep 18, 2026
Open
$1.60
From 52W high
−60.74%
Volume
73100.00
Market cap
$121.52M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.3x
P/E (TTM)
—
RSI (14)
50.9
MomentumView details →
1D Return
−2.45%
YTD Return
−5.17%
SummaryUpdated Jun 1, 2026
Cibus, Inc. (NASDAQ:CBUS) is a San Diego-based agricultural biotechnology company founded in 2001 that develops gene-edited plant traits for licensing to seed companies. The company went public in July 2017 and has evolved from a research-focused organization into a commercial gene editing platform. Cibus specializes in developing productivity traits that help farmers achieve higher yields while reducing chemical inputs, as well as sustainable ingredients that can replace fossil fuel-based components in various products.
Similar companies
Latest newsMore news →